Global Vaccine Administration Devices Market is expected to grow with the CAGR of 7.4% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.
Global vaccine administration devices market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in global vaccine administration devices market are introducing strong range of products provider along with launching new products and adopting strategic initiatives such as acquisition, agreement, business expansion, award and recognition into the vaccine administration devices market. This helped companies to maximize the sales with enhanced product portfolio. For instance, in October 2019, Gerresheimer AG opened a new Glass Innovation and Technology Centre in the U.S. for enhancing the manufacturing of glass containing products. As the company is engaged in manufacturing of glass prefilled syringes used for vaccine administration, this expansion has helped the company to enhance the manufacturing of vaccine administration devices.
BD is the dominating player in global vaccine administration devices market. The other key players existing in the vaccine administration devices market includes INOVIO Pharmaceuticals, PharmaJet, Vaxxas Pty Ltd, Gerresheimer AG, Corium Inc., iHealthNet LLC, Enesi, Micropoint Technologies, SCHOTT AG (a subsidiary of Carl-Zeiss-Stiftung), 3M, Mystic Pharmaceuticals, Star Syringe Limited, NanoPass, Terumo Europe NV (a subsidiary of Terumo Corporation), D'Antonio Consultants International, Inc., West Pharmaceutical Services, Inc., Bespak Europe Ltd., Mylan Pharmaceuticals Inc. (a subsidiary of Mylan N.V.), Medical International Technologies (MIT Canada) Inc., Antares Pharma, and InjexUK among others.
BD headquartered in New Jersey, U.S. was founded in 1897. The company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company has multiple business segments including medical, life science, and interventional, in these life sciences is the market focused segment. The company has wide product portfolio such as anesthesia delivery, biosciences, biosurgery, cervical cancer screening, diabetes care, drug delivery systems, gastrointestinal care, hazardous drug safety, hernia repair and fixation home care, infection prevention, infusion therapy, and other variety of products, in which drug delivery systems is the market focused category.
The company has wide presence across North America, Europe, South America, Asia-Pacific, and Middle East and Africa. The company also has various subsidiary companies such as Accuri Cytometers, Inc. (U.S.), BD Holding S. de R.L. de C.V. (Mexico), BD Rapid Diagnostic (Suzhou) Co., Ltd. (China), Becton, Dickinson A.G. (Switzerland), Carmel Pharma AB (Sweden) among others.
Terumo Europe NV (a subsidiary of Terumo Corporation):
Terumo Europe NV (a subsidiary of Terumo Corporation) headquartered in Leuven, Belgium. The company focuses on providing valuable products and services to achieve sustainable growth, maximize long-term corporate value and meet the expectations of its worldwide stakeholders. The company has wide product portfolio including ablation systems, accessories, catheters, closure devices, coils, electromechanical products, filters, guidewire, imaging, microspheres, monitoring systems, needle & syringes, perfusion products, safety devices, sheaths, stents, and surgical products in which needle & syringes is the market focused product category.
The company has presence across Europe, and Middle East. The company also has various subsidiary companies such as Terumo Deutschland GmbH (Switzerland), Terumo Europe España SL (Spain), Terumo France S.A.S. (France), Terumo Italia S.r.l Unipersonale (Italy), Terumo Poland Sp. z o.o. (Poland) among others.
Gerresheimer AG headquartered in Düsseldorf, Germany was founded in 1864. The company is engaged in manufacturing of specialty glass and plastic products for safe, simple administration of medicines using inhalers, micro pumps, prefillable syringes, injection vials among others. The company operates its business through multiple business segments which are plastic & devices, primary packaging glass, and advanced technologies in which primary packaging glass is the market focused segment. The company is engaged in providing wide range of product categories such as pharmaceutical primary packaging, customers- specific drug delivery systems, medical devices and diagnostics products, micro pumps, food & beverage, life science among others in which pharmaceutical primary packaging is the market focused product category.
The company has presence across North America, Europe, South America, Asia-Pacific, and Middle East and Africa. The company has several owned subsidiaries involving Gerresheimer Group GmbH (Germany), Gerresheimer Regensburg GmbH (Germany), Gerresheimer item GmbH (Germany), Gerresheimer Tettau Gmbh (Germany), Kimble Glass Company (U.S.) among others.
Global Vaccine Administration Devices Market– Industry Trends and Forecast to 2029
Europe Vaccine Administration Devices Market – Industry Trends and Forecast to 2027
Middle East and Africa Vaccine Administration Devices Market - Industry Trends and Forecast to 2027
North America Vaccine Administration Devices Market – Industry Trends and Forecast to 2027
Asia-Pacific Vaccine Administration Devices Market – Industry Trends and Forecast to 2027